drugset
drugset / Trial / NCT03972397

Intercostal Nerve Cryoablation for Postoperative Pain Management

NCT03972397 ↗

Phase 4 Completed 20 enrolled The University of Texas Health Science Center, Houston
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.

Timeline

Start
2019-07-15
Primary completion
2022-09-22
Completion
2022-09-22

Drugs

EvaluationDrugModalityDoseRoute
Background Bupivacaine Other / unclassified 266 mg —
Background Hydromorphone Other / unclassified 0.2 mg —
Background Hydromorphone Other / unclassified 0.4 mg —
Background Hydromorphone Other / unclassified 2 mg —

Indications

No indication recorded.